Digestive Diseases and Sciences

, Volume 50, Issue 2, pp 351–356 | Cite as

A One-Year Follow-up Study of Endoluminal Gastroplication (Endocinch) in GERD Patients Refractory to Proton Pump Inhibitor Therapy

  • J. Arts
  • T. Lerut
  • P. Rutgeerts
  • D. Sifrim
  • J. Janssens
  • J. Tack


In a subset of patients with gastroesophageal reflux disease (GERD), symptoms persist in spite of proton pump inhibitor (PPI) therapy. Endoscopic gastroplication (EG) was reported to provide a novel therapeutic option in GERD. To evaluate symptomatic and objective outcome of EG in PPI refractory GERD, consecutive GERD patients with persisting reflux symptoms during at least 2 months double dose PPI were recruited for EG (Endocinch). Exclusion criteria were high-grade esophagitis, Barrett’s esophagus, and hiatal hernia >3 cm. Symptoms and PPI use were evaluated before and 1, 3, and 12 months after the EG; 24-hr pH monitoring off PPI was performed before and after 3 and 12 months. All data are given as mean ± SD and were analyzed by Student’s t test. Twenty patients (10 females; mean age, 45 ± 11 years) were recruited. Under conscious sedation with midazolam (6 ± 2 mg) and pethidine (53 ± 5 mg), a mean of 2.0 ± 0.2 sutures was applied during a procedure time of 33 ± 6 min. Throat ache and mild epigastric pain for up to 3 days after the procedure were the only adverse events. At 3 and 12 months symptom score (11.6 ± 6 vs. 6.4 ± 3.7 [P < 0.01] and 7.1 ± 4.5 [P < 0.05]) as well as pH monitoring (% time pH < 4: 17.0 ± 1.1 vs. 8.1 ± 5.7% [P < 0.01] and 9.8 ± 4.1% [P < 0.01]) significantly improved. Ph monitoring was normalized (<4% of time) in seven patients after 3 months. PPIs could be stopped in 13 patients, with 2 patients still using H2-blockers and 1 using cisapride after 3 months. After 12 months only six patients were free of PPI use and pH monitoring was normalized in six patients. We conclude that EG provides short- and medium-term symptomatic and objective relief to a subset of GERD patients refractory to high-dose PPI.


endoluminal gastroplication proton pump inhibitor gastroesophageal reflux disease pH monitoring 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Wienbeck M, Barnert J: Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 24(Suppl 56):7–13, 1989Google Scholar
  2. Nebel OT, Fornes MF, Castell DO: Symptomatic gastroesophageal reflux: incidence and precipitating actors. Am J Dig Dis 21(11):953–956, 1976PubMedGoogle Scholar
  3. Lagergren J, Bergström R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831, 1999CrossRefPubMedGoogle Scholar
  4. Bardhan KD: The role of proton pomp inhibitors in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther Suppl 1:15–25, 1999Google Scholar
  5. Leite L, Johnston B, Just R, Castell D: Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91(8):1527–1531, 1996PubMedGoogle Scholar
  6. Beldi G, Glattli A: Long-term gastrointestinal symptoms after laparoscopic Nissen fundoplication. Surg Laparosc Endosc Percutan Techn 12(5):316–319, 2002Google Scholar
  7. Lundell L: Protagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Gut 51:468–472, 2002PubMedGoogle Scholar
  8. Galmiche J, Zerbib F: Antagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Gut 51:472–272, 2002Google Scholar
  9. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufmann JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W: Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. JAMA 285(18):2331–2338, 2000Google Scholar
  10. Vakil N, Shaw M, Kirby R: Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med 114:1–5, 2003Google Scholar
  11. Campos GMR, Peeters JH, DeMeester TR, Oberg F, Crookes PF, Tan S, DeMeester SR, Hagen JA, Bremner CG: Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3:292–300, 1999CrossRefPubMedGoogle Scholar
  12. Waring JP, Hunter JG, Oddsdottir MWoJ, Katz E: The preoperative evaluation of patients considered for laparoscopic antireflux surgery. Am J Gastroenterol 90:35–38, 1995PubMedGoogle Scholar
  13. Arts J, Tack J, Galmiche JP: Endoscopic anti-reflux procedures. Gut 53:1207–1216, 2004PubMedGoogle Scholar
  14. Swain CP, Mills TN: An endoscopic sewing machine. Gastrointest Endosc 32:36–38, 1986PubMedCrossRefGoogle Scholar
  15. Swain CP, Kadirkamanathan SS, Gong F, Lai KC, Ratani RS, Brown GJ, Mills TN: Knot tying at flexible endoscopy. Gastrointest Endosc 40:722–729, 1994PubMedGoogle Scholar
  16. Kadirkamanathan SS, Evans DF, Gong F, Yawaki E, Scott M, Swain CP: Antireflux operations at flexible endoscopy using endoluminal stitching techniques: an experimental study. Gastrointest Endosc 44:133–143, 1996PubMedGoogle Scholar
  17. Filipi CJ, Lehman GA, Rothstein RI, Raijman I, Steigmann GV, Waring JP, Hunter JG, Gostout CJ, Edmundowicz SA, Dunne DP, Watson PA, Cornet DA: Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial. Gastrointest Endosc 51(4):416–423, 2001Google Scholar
  18. Mahmood Z, McMahon B, Khosa F, Trimble V, Frayne P, Weir D: Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut 52:34–39, 2003CrossRefPubMedGoogle Scholar
  19. Swain C, Park P, Kjellin T, Gong F, Kadirkamanathan S, Applleyard M: Endoscopic gastroplasty for gastro-esophageal reflux disease. Gastrointest Endosc 51:AB144, 2000Google Scholar
  20. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J: The effect of the GABAb agonist baclofen in patients with symptoms and duodenogastro-esophageal reflux refractory to proton pump inhibitors . Gut 10:1397–1402, 2003Google Scholar
  21. Ollyo JB, Lang F, Fonttolliet C, Monnier P: Savary-Miller’s new endoscopic grading of reflux-esophagitis: a simple, reproducible, logical, complete and useful classification. Gastroenterology 98:A100, 1990Google Scholar
  22. Tack J, Bisschops R, Koek GH, Sifrim D, Lerut T, Janssens J: Dietary restrictions during ambulatory monitoring of duodeno-gastro-esophageal reflux. Dig Dis Sci 48:1213–1220, 2003CrossRefPubMedGoogle Scholar
  23. Velanovich V, Ben-Menachem T, Goel S: Case-control comparison of endoscopic gastroplication with laparoscopic fundoplication in the management of gstroesophageal reflux disease: early symptomatic outcomes. Surg Laparosc Endosc Percutan Tech 12:219–223, 2002PubMedGoogle Scholar
  24. Haber GB, Marcon NE, Kortan P, Kandel G, Cirocco M, Basset N: A 2 year follow up of 25 patients undergoing endoluminal gastric plication (ELGP) for gastroesophageal reflux disease (GERD). Gastrointest Endosc 53:AB3430, 2001Google Scholar
  25. Raijman I, Ben-Menachem T, Reddy G, Chen Y: Symptomatic response to endoluminal gastroplication (ELGP) in patients with gastroesophageal reflux disease (GERD): a multicenter experience. Gastrointest Endosc 53:AB738, 2001Google Scholar
  26. Park P, Kjellin T, Swain P: Results of endoscopic gastroplasty for gastroesophageal reflux disease. Gastrointest Endosc 53:AB3427, 2001Google Scholar
  27. Velanovich V, Ben Menachem T: Laparoscopic Nissen fundoplication after failed endoscopic gastroplication. J Laparoendosc Adv Surg Techn 12:305–308, 2002Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • J. Arts
    • 1
  • T. Lerut
    • 2
  • P. Rutgeerts
    • 1
  • D. Sifrim
    • 1
  • J. Janssens
    • 1
  • J. Tack
    • 1
  1. 1.Departments of Gastroenterology and EndoscopyUniversity Hospitals LeuvenLeuvenBelgium
  2. 2.Department of Thoracic and Esophageal SurgeryUniversity Hospitals LeuvenLeuvenBelgium

Personalised recommendations